GENIKI GRAMMATIA EREVNAS KAI KAINOTOMIAS

Their core work

Greece's national government body responsible for research and innovation policy and funding. GSRI acts as the Greek funding agency in ERA-NET Cofund schemes, committing national funds to transnational research calls across energy, health, quantum technologies, agriculture, and environment. Their role in H2020 is not as a research performer but as a policy and funding partner — they co-design joint calls, align Greek national research priorities with European agendas, and channel Greek public funding into coordinated European research programmes. They are the gateway for Greek researchers to access co-funded transnational opportunities.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2018), GSRI focused heavily on research infrastructure support, FET Flagships (Graphene, Human Brain Project), nanomedicine, and foundational quantum technologies — reflecting a priority on frontier science and building national research capacity. From 2019 onward, their portfolio broadened significantly into applied societal challenges: rare diseases, agri-food systems, biodiversity-climate interactions, antimicrobial resistance, and Green Deal-aligned materials research. This shift mirrors the EU's own pivot from excellence-driven to mission-oriented research funding.

GSRI is increasingly aligning Greek national funding with EU Green Deal and health mission priorities, making them a reliable co-funding partner for applied, impact-oriented ERA-NET proposals.

How they like to work

GSRI participates exclusively as a partner, never as coordinator — consistent with their role as a national funding agency joining multilateral ERA-NET schemes. With 291 unique consortium partners across 45 countries, they operate in very large, pan-European networks of funding bodies. Working with GSRI means gaining access to Greek national co-funding for transnational calls; they are not a research performer but a funding enabler.

Exceptionally broad network of 291 partners across 45 countries, reflecting their role in large ERA-NET consortia that typically include 20-40 national funding agencies. Their reach is truly pan-European and extends to associated countries.

What sets them apart

GSRI is Greece's primary gateway to ERA-NET co-funded research. Unlike research institutes or universities, they bring national budget commitments to the table — their participation in an ERA-NET means Greek researchers can apply for funded positions in that call. For consortium builders designing new ERA-NETs, GSRI's involvement signals that Greece will commit public funds, which strengthens the proposal and broadens geographic coverage.

Highlights from their portfolio

• E-Rare-3
  Their highest-funded project (EUR 150,597), supporting IRDiRC objectives for rare disease research — showing strong Greek commitment to this area.
• QuantERA II
  Second-generation quantum technologies ERA-NET, demonstrating sustained Greek investment in quantum research across computing, communication, and sensing.
• M-ERA.NET3
  Their most recent thematic expansion into materials and battery technologies aligned with the European Green Deal, signaling new strategic priorities.